Literature DB >> 29463664

Are All Patients With Type 1 Diabetes Destined for Dialysis if They Live Long Enough? Probably Not.

George L Bakris1, Mark Molitch2.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 29463664     DOI： 10.2337/dci17-0047

Source DB:  PubMed          Journal:  Diabetes Care        ISSN： 0149-5992            Impact factor:   19.112


× No keyword cloud information.
  8 in total

Review 1.  Inpatient Glycemic Management in the Setting of Renal Insufficiency/Failure/Dialysis.

Authors:  Ravi Iyengar; Jennifer Franzese; Roma Gianchandani
Journal:  Curr Diab Rep       Date:  2018-08-15       Impact factor: 4.810

2.  A Targeted Multiomics Approach to Identify Biomarkers Associated with Rapid eGFR Decline in Type 1 Diabetes.

Authors:  Christine P Limonte; Erkka Valo; Daniel Montemayor; Farsad Afshinnia; Tarunveer S Ahluwalia; Tina Costacou; Manjula Darshi; Carol Forsblom; Andrew N Hoofnagle; Per-Henrik Groop; Rachel G Miller; Trevor J Orchard; Subramaniam Pennathur; Peter Rossing; Niina Sandholm; Janet K Snell-Bergeon; Hongping Ye; Jing Zhang; Loki Natarajan; Ian H de Boer; Kumar Sharma
Journal:  Am J Nephrol       Date:  2020-10-14       Impact factor: 3.754

3.  Urinary Proteomics Identifies Cathepsin D as a Biomarker of Rapid eGFR Decline in Type 1 Diabetes.

Authors:  Christine P Limonte; Erkka Valo; Viktor Drel; Loki Natarajan; Manjula Darshi; Carol Forsblom; Clark M Henderson; Andrew N Hoofnagle; Wenjun Ju; Matthias Kretzler; Daniel Montemayor; Viji Nair; Robert G Nelson; John F O'Toole; Robert D Toto; Sylvia E Rosas; John Ruzinski; Niina Sandholm; Insa M Schmidt; Tomas Vaisar; Sushrut S Waikar; Jing Zhang; Peter Rossing; Tarunveer S Ahluwalia; Per-Henrik Groop; Subramaniam Pennathur; Janet K Snell-Bergeon; Tina Costacou; Trevor J Orchard; Kumar Sharma; Ian H de Boer
Journal:  Diabetes Care       Date:  2022-06-02       Impact factor: 17.152

4.  Biomarkers for Detecting Kidney Dysfunction in Type-2 Diabetics and Diabetic Nephropathy Subjects: A Case-Control Study to Identify Potential Biomarkers of DN to Stratify Risk of Progression in T2D Patients.

Authors:  Carla Harkin; Diego Cobice; Simon Brockbank; Stephanie Bolton; Frances Johnston; Anna Strzelecka; Joanne Watt; Mary Jo Kurth; John V Lamont; Peter Fitzgerald; Tara Moore; Mark W Ruddock
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-29       Impact factor: 6.055

5.  Comparison of Performance of Equations for Estimated Glomerular Filtration Rate in Chinese Patients with Biopsy-Proven Diabetic Nephropathy.

Authors:  Yiting Wang; Junlin Zhang; Geer Teng; Yucheng Wu; Qianqian Han; Hanyu Li; Tingli Wang; Fang Liu
Journal:  Dis Markers       Date:  2019-09-15       Impact factor: 3.434

6.  Predicting renal disease progression in a large contemporary cohort with type 1 diabetes mellitus.

Authors:  Marco Colombo; Stuart J McGurnaghan; Samira Bell; Finlay MacKenzie; Alan W Patrick; John R Petrie; John A McKnight; Sandra MacRury; Jamie Traynor; Wendy Metcalfe; Paul M McKeigue; Helen M Colhoun
Journal:  Diabetologia       Date:  2019-12-05       Impact factor: 10.122

7.  Circulating short and medium chain fatty acids are associated with normoalbuminuria in type 1 diabetes of long duration.

Authors:  Salina Moon; John J Tsay; Heather Lampert; Zaipul I Md Dom; Aleksandar D Kostic; Adam Smiles; Monika A Niewczas
Journal:  Sci Rep       Date:  2021-04-21       Impact factor: 4.996

8.  Variations in Risk of End-Stage Renal Disease and Risk of Mortality in an International Study of Patients With Type 1 Diabetes and Advanced Nephropathy.

Authors:  Jan Skupien; Adam M Smiles; Erkka Valo; Tarunveer S Ahluwalia; Beata Gyorgy; Niina Sandholm; Stephanie Croall; Maria Lajer; Kevin McDonnell; Carol Forsblom; Valma Harjutsalo; Michel Marre; Andrzej T Galecki; David-Alexandre Tregouet; Chun Yi Wu; Josyf C Mychaleckyj; Helen Nickerson; Marlon Pragnell; Stephen S Rich; Marcus G Pezzolesi; Samy Hadjadj; Peter Rossing; Per-Henrik Groop; Andrzej S Krolewski
Journal:  Diabetes Care       Date:  2018-11-19       Impact factor: 19.112
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.